Development of a Motivational Intervention to Improve Treatment Adherence in MS
Completed · Not applicable
Conditions studied: Relapsing-remitting Multiple Sclerosis
In brief
As many as 50% of MS patients prematurely discontinue their disease modifying medications. For this study, we will develop a telephone-based talk therapy intervention and then conduct a randomized controlled trial. Patients will be assigned to either 5 weekly 20 minute telephone sessions of psychotherapy or a brief education control condition. We hypothesize that patients undergoing phone therapy will be more likely to indicate they are interested in resuming taking disease modifying medications than patients given brief education and treatment as usual.
Key facts
- Study ID
- NCT01925690
- Run by
- University of Missouri, Kansas City
- People needed
- 80
- Starts
- 2013-02-01
- Expected to finish
- 2015-09-01
- Last updated by the study team
- 2015-12-02
Who can join
Age: 18 and older. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- Diagnosis of relapsing remitting MS based on established guidelines
- Previously discontinued recommended therapy
- Provider recommendation for DMT re-initiation
- At least 18 years of age
- Access to a telephone
- English speaking
You may not qualify if…
- Diagnosis other than relapsing remitting MS
- Provider does not recommend DMT re-initiation
- Pregnant or breastfeeding (females)
Where it is running
- University of Missouri-Kansas City — Kansas City, Missouri, United States
- Kessler Rehabillitation Institute — West Orange, New Jersey, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.